» Articles » PMID: 17504879

Partial-volume Effect in PET Tumor Imaging

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2007 May 17
PMID 17504879
Citations 542
Authors
Affiliations
Soon will be listed here.
Abstract

PET has the invaluable advantage of being intrinsically quantitative, enabling accurate measurements of tracer concentrations in vivo. In PET tumor imaging, indices characterizing tumor uptake, such as standardized uptake values, are becoming increasingly important, especially in the context of monitoring the response to therapy. However, when tracer uptake in small tumors is measured, large biases can be introduced by the partial-volume effect (PVE). The purposes of this article are to explain what PVE is and to describe its consequences in PET tumor imaging. The parameters on which PVE depends are reviewed. Actions that can be taken to reduce the errors attributable to PVE are described. Various PVE correction schemes are presented, and their applicability to PET tumor imaging is discussed.

Citing Articles

F-18 FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell lung cancer.

Oh J, Lee S, Park Y BMC Cancer. 2025; 25(1):379.

PMID: 40022020 PMC: 11871754. DOI: 10.1186/s12885-025-13727-7.


A Method for Calculating Small Sizes of Volumes in Postsurgical Thyroid SPECT/CT Imaging.

Ttofi E, Kyriacou C, Leontiou T, Parpottas Y Life (Basel). 2025; 15(2).

PMID: 40003609 PMC: 11856228. DOI: 10.3390/life15020200.


Towards automatical tumor segmentation in radiomics: a comparative analysis of various methods and radiologists for both region extraction and downstream diagnosis.

Yu Y, Li G, Tan W, Qu X, Zhang T, Hou X BMC Med Imaging. 2025; 25(1):63.

PMID: 40000987 PMC: 11863488. DOI: 10.1186/s12880-025-01596-2.


Calculation of recovery coefficients for partial volume effect correction in PET/CT imaging using a customized anthropomorphic body phantom.

Yavuz G, Kovan B, Toklu T, Cermik T, Ozturk C Biomed Eng Online. 2025; 24(1):20.

PMID: 39955528 PMC: 11830175. DOI: 10.1186/s12938-025-01330-7.


Baseline F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters.

Taralli S, Orlandi A, Pafundi P, Tempesta V, Di Leone A, Pontolillo L Radiol Med. 2025; 130(3):422-437.

PMID: 39937369 DOI: 10.1007/s11547-025-01961-9.